Cargando…
Does IHU-Méditerranée Infection influence Gilead Sciences' stock price?
During COVID-19 pandemic the Gilead Sciences stock prices rose sharply with large variations. These fluctuations have been tentatively related to communications, publications or leaks about remdesivir or hydroxychloroquine/azithromycin treatment.
Autor principal: | Chabrière, E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7525330/ https://www.ncbi.nlm.nih.gov/pubmed/33014379 http://dx.doi.org/10.1016/j.nmni.2020.100711 |
Ejemplares similares
-
Naming microorganisms: the contribution of the IHU Méditerranée Infection, Marseille, France
por: Lagier, J.-C., et al.
Publicado: (2018) -
COVID-19 Management at IHU Méditerranée Infection: A One-Year Experience
por: Brouqui, Philippe, et al.
Publicado: (2021) -
Discovery and Further Studies on Giant Viruses at the IHU Mediterranee Infection That Modified the Perception of the Virosphere
por: Rolland, Clara, et al.
Publicado: (2019) -
Paying Attention to Beauty (Gilead)
por: Hibbs, Stephen, et al.
Publicado: (2021) -
What Does the COVID-19 Pandemic Mean for Rheumatology Patients?
por: Pope, Janet E.
Publicado: (2020)